C57BL/6JGpt-Tcea3em15Cd6735in1/Gpt

Mouse Model: Tcea3-KO
Strain Number: T029489

Knockout (KO)

  • Product Type:
  • Quantity: - +
  • Sex:
  • Age:
  • Genotype:

GemPharmatech Offers the World’s Largest Knockout and Conditional Knockout Library

With over 25,000 mouse models available and thousands of new strains developed annually, GemPharmatech has built the world’s largest knockout and conditional knockout resource library. Every model is generated using cutting-edge gene editing and validated at the genomic level to ensure reliability. Choosing GemPharmatech means more than acquiring a mouse model, it means partnering with a global leader committed to scientific rigor, competitive pricing, and timely delivery of the mice models your research requires.

BASIC INFORMATION
Strain Name: C57BL/6JGpt-Tcea3em15Cd6735in1/Gpt
Strain Number: T029489
Official Symbol: Tcea3
Strain Strategy: T029489.Tcea3 Cas9-KO Strategy-EN.pdf
Official Full Name: transcription elongation factor A (SII), 3
Also Known As: S-II,SII-K1
NCBI Number: 21401
MGI Number: 1196908
Chromosome: 4
Deletion (size): -6735bp+1bp
Research Areas: immune system,nervous system,vision/eye,Physiological system,hematopoietic system,Cell biology,cell nucleus,Molecular biology,DNA transcription,DNA binding protein
Strain Background: [N000013] C57BL/6JGpt
Modification Type: Knockout (KO)
Genotyping Protocols: T029489. Tcea3 Genotyping Protocol(KO).pdf
Inventory Status: Cryopreserved
Sale Status: IF (Available for Distribution)
Health Status: Specific pathogen free (SPF)
Health Report: Please log in to view

Extend the Value of Your Mouse Models with Integrated Preclinical Services

GemPharmatech not only provides access to advanced genetically engineered mouse models but also offers comprehensive preclinical research services to help you maximize their value. Our scientific team can support your studies from model construction through phenotype validation and pharmacology testing, ensuring that every experiment is designed for translational relevance. By pairing this conditional knockout model with GemPharmatech’s preclinical services, you gain an integrated workflow that accelerates discovery, reduces risk, and produces robust, actionable data.